Skip to main content
. 2024 Jun 17;70(6):e20231390. doi: 10.1590/1806-9282.20231390

Table 1. Demographic and clinical characteristics of patients in the study groups at the time of diagnosis.

Variables Group 1 (n=258) Group 2 (n=35) Total (n=293) p-value
Age (years) 28 (24–32) 34 (26–37) 28 (24–33) 0.001
BMI (kg/m 2 ) 29 (26–32) 32 (28–35) 29 (26–33) 0.005
Gravidity (number) 3 (2–3) 3 (2–4) 3 (2–4) 0.012
Parity (number) 1 (0–2) 2 (1–3) 1 (1–2) 0.022
Previous cesarean delivery 0 (0–0) 0 (0–1) 0 (0–0) 0.073
Miscarriage (number) 0 (0–0) 0 (0–1) 0 (0–0) 0.734
MVP of amniotic fluid (mm) 95 (87–109.2) 97 (85–110) 95 (87–110) 0.857
Mild 227 (88%) 31 (88.6%) 258 (88.1%) 0.322
Moderate 25 (9.7%) 2 (5.7%) 27 (9.2%)
Severe 6 (2.3%) 2 (5.7%) 8 (2.7%)
Fasting blood glucose (g/dL) 80 (75–88) 79 (71–98) 79.5 (75–88.2) 0.931
Postprandial blood glucose (g/dL) 113.2±22.2 116.1±34.3 113.9±24.9 0.013
HbA1c (%) 5.1±0.4 5.9±0.8 5.3±0.6 <0.001

BMI: body mass index; HbA1c: glycated hemoglobin; MVP: maximum vertical pocket; PHA: polyhydramnios. Data are expressed as median (Q1–Q3), mean±standard deviation or number (percentage) where appropriate. A p<0.05 indicates a significant difference. Statistically significant p-values are indicated in bold.